A recent Radiology study has identified a new marker for lymph node metastasis in rectal cancer.

In a study of 1,071 patients with resectable tumors, those lacking a three-layered “dark-light-dark” sign on MRI were more likely to have lymph node involvement. Lead author Xin-Yue Yan from Peking University Cancer Hospital and Institute in Beijing suggests this finding could enhance preoperative assessments and treatment planning.

Lymph node metastasis is a critical predictor of cancer spread, local recurrence, and survival. When lymph nodes are involved, five-year survival rates drop from 92% to 37%. Accurate early detection is crucial for making treatment decisions, such as whether to proceed with local resection, mesorectal excision, or neoadjuvant therapy for early-stage tumors (T1–T2).
Current MRI methods primarily focus on lymph node size and shape, guided by the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guidelines. However, these approaches have limitations, including variations in imaging techniques, interpretation, and tumor characteristics.

To improve accuracy, the study tested two models: one using nonenhanced MRI combined with clinical data and ESGAR guidelines, and another incorporating the dark-light-dark sign. This sign, characterized by slight tumor enhancement with strong surrounding enhancement, was associated with a lower risk of lymph node metastasis when present, and a higher risk when absent.

When tested externally, the model that included the dark-light-dark sign achieved an area under the curve (AUC) of 0.83, outperforming models based on lymph node size, ESGAR guidelines, or nonenhanced MRI (AUC range, 0.69–0.79). The consistency in interpreting the sign suggests it can be reliably used in clinical practice.

The study involved 922 patients in the main group and 149 in a separate test group. Patients with lymph node involvement were more likely to have elevated levels of carcinoembryonic antigen (CEA) and CA 19-9, both cancer-related markers. MRI features such as vein invasion and damage to the rectum's outer muscle layer were linked to a higher risk of cancer spread.

These findings suggest that tumor-specific MRI features, particularly the dark-light-dark sign, could improve preoperative assessments and treatment planning, potentially reducing both under- and overtreatment in early-stage rectal cancer. Future studies should validate these results across centers and explore AI-driven tools to refine clinical decision-making, say Yan and his coauthors.

Back to HCB News

MRI Homepage